Diet or drugs? new study tests if fasting beats pills for fatty liver disease
NCT ID NCT06845345
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a Mediterranean diet combined with intermittent fasting can reduce liver scarring (fibrosis) better than the weight-loss medication naltrexone/bupropion. About 70 adults with overweight or obesity and heart or metabolic risks (like type 2 diabetes or high blood pressure) will be followed for six months. The goal is to see if the diet approach is a safer or more effective way to manage fatty liver disease and prevent long-term liver damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIO METABOLIC RISK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Franciscus
Rotterdam, 3045 PM, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a few short nights of sleep tip the scales toward high blood pressure?
- Chatbot could put blood pressure control in Patients' hands
- Can a 5-Step chat help tame high blood pressure?
- Can a heart drug tame blood sugar and weight in diabetes?
- Can artery scans reveal hidden damage from high blood pressure?
- Can a puff of insulin replace a needle for diabetes?